Nir Arbel
Corporate Officer/Principal bij EVOGENE LTD.
Vermogen: - $ op 31-03-2024
Profiel
Nir Arbel is the founder of Carmentix Pte Ltd.
He is currently working as the Chief Product Officer at Evogene Ltd.
He holds a doctorate degree from Ben-Gurion University of the Negev.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EVOGENE LTD
-.--% | 17-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Nir Arbel
| Bedrijven | Functie | Begin |
|---|---|---|
| EVOGENE LTD. | Corporate Officer/Principal | 01-08-2021 |
Eerdere bekende functies van Nir Arbel
| Bedrijven | Functie | Einde |
|---|---|---|
Carmentix Pte Ltd.
 Carmentix Pte Ltd. Packaged SoftwareTechnology Services Carmentix Pte Ltd. operates as a venture backed startup company developing a novel biomarker prognostic panel for pre term birth. It specializes in diagnostics, preterm birth and preeclampsia. The company was founded in 2015 and is headquartered in Singapore. | Chief Executive Officer | - |
Opleiding van Nir Arbel
| Ben-Gurion University of the Negev | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| EVOGENE LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Carmentix Pte Ltd.
Carmentix Pte Ltd. Packaged SoftwareTechnology Services Carmentix Pte Ltd. operates as a venture backed startup company developing a novel biomarker prognostic panel for pre term birth. It specializes in diagnostics, preterm birth and preeclampsia. The company was founded in 2015 and is headquartered in Singapore. | Technology Services |
